Dr. Zakai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Prospect St
# 89
Burlington, VT 05405Phone+1 802-847-5971Fax+1 802-847-5946
Education & Training
- Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Vermont Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of Virginia School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2021 - 2026
- VT State Medical License 2000 - 2026
- RI State Medical License 2005 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 57 citationsDiabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.Elizabeth J. Bell, Aaron R. Folsom, Pamela L. Lutsey, Elizabeth Selvin, Neil A. Zakai
Diabetes Research and Clinical Practice. 2016-01-01 - 86 citationsAlbuminuria, Kidney Function, and the Incidence of Cognitive Impairment Among Adults in the United StatesManjula Kurella Tamura, Paul Muntner, Virginia G. Wadley, Mary Cushman, Neil A. Zakai
American Journal of Kidney Diseases. 2011-11-01 - 73 citationsValidating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.Sarah R Gillett, Rebekah H. Boyle, Neil A. Zakai, Leslie A. McClure, Nancy S. Jenny
Clinical Biochemistry. 2014-08-14
Journal Articles
- All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous ThromboembolismNeil A Zakai, Terrence J Adam, Thrombosis and Haemostasis
- Mechanisms and Mitigating Factors for Venous Thromboembolism in Chronic Kidney Disease: The REGARDS StudyM Cushman, N A Zakai, G Howard, Journal of Thrombosis and Haemostasis
- Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)Monika M Safford, Mary Cushman, Brett Kissela, Neil A Zakai, Thrombosis and Haemostasis
Abstracts/Posters
- Post Discharge Risk of Venous Thromboembolism in a Primary Care PopulationNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the ChildrenÍs Hospital-Acquired Thrombosis (CHAT) ConsortiumNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine LearningNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Diagnosis and Follow‐up of Thrombotic Thrombocytopenic Purpura with an Automated Chemiluminescent ADAMTS13 Activity ImmunoassayDecember 15th, 2020
- Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel MethodDecember 8th, 2020
- Racial Differences in Protein S Tokushima and Two Protein C Variants as Genetic Risk Factors for Venous ThromboembolismOctober 20th, 2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: